Chemoinformaics analysis of 2-Ethylhexanoic acid
| Molecular Weight | 144.214 | nRot | 5 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 1 |
| Exact Molecular Weight | 144.115 | nRing | 0 |
| Solubility: LogS | -1.276 | nHRing | 0 |
| Solubility: LogP | 1.689 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 25.6327 |
| nHD | 1 | BPOL | 16.9193 |
| QED | 0.411 |
| Synth | 1.654 |
| Natural Product Likeliness | 0.614 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.005 |
| HIA | 0.003 |
| CACO-2 | -4.215 |
| MDCK | 0.0000309 |
| BBB | 0.997 |
| PPB | 0.374616 |
| VDSS | 0.906 |
| FU | 0.768469 |
| CYP1A2-inh | 0.939 |
| CYP1A2-sub | 0.278 |
| CYP2c19-inh | 0.256 |
| CYP2c19-sub | 0.684 |
| CYP2c9-inh | 0.052 |
| CYP2c9-sub | 0.226 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.249 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.254 |
| CL | 7.221 |
| T12 | 0.778 |
| hERG | 0.028 |
| Ames | 0.012 |
| ROA | 0.03 |
| SkinSen | 0.554 |
| Carcinogencity | 0.272 |
| EI | 0.991 |
| Respiratory | 0.095 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.942148 |